Floatz logo

Capecitabine

Radiotherapy

Tao ZhangSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
73/ 100

Competitive context

39 Active assets in the Radiotherapy cohort.

Asset / SponsorPhaseRating
Pembrolizumab
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4B
Toripalimab
Northern Jiangsu People's Hospital
Phase 3B
Eloxatin
Tao Zhang
Phase 3B
Nivolumab
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4B
Axitinib
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4B

View all 42 →

Same molecule, other indications

Capecitabine is also rated in:

Locally Advanced Rectal CancerDormant
BBB
Indicative ·
75 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →
rectal carcinomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →